Comparative study on effect of alkaline preparation of two species of chiraita processed in Buffalo urine in loss of digestive power.

Comparative clinical study on kshar of Swertia chirayata roxb. Flem. and Swertia angustifolia buch-ham.Exd.Don,processed in mahish mootra w.s.r.to agnideepan activity.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017047

Enrollment

Registered

2019-01-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

Intervention1: Kshar of Swertia angustifolia .: Kshar of Swertia angustifolia 1gm/day in two divided doses will be given orally for 21 days with 3gm melted ghee. Control Intervention1: Kshar of Swe

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having classical signs and symptoms of jatharagnimandhya like Avipaka, Chardi, Angamard, Udara Gaurav, Ksudhanasa, Mukha durgandha, etc will be selected. 2.Patients of either sex with age group between 20 to 70 years will be selected.

Exclusion criteria

Exclusion criteria: Patients with chronic disease like severe Hypertension, IHD, COPD, DM, cancer, Hepatic and renal insufficiency, psychotic disorders like depression, schizophrenia. 2.Any acute illness /serious illness. 3.Pregnant women and lactating mothers.

Design outcomes

Primary

Measure	Time frame
Improvement in subjective and objective parameters.Timepoint: 21days	—

Secondary

Measure	Time frame
To find comparative efficacy of either treatment.Timepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Sabita Sapkota

National Institute of Ayurveda

sapkotasabita1988@gmail.com09587112737

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026